These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2016-003452-75 A PHASE 2B RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL ADAPTIVE 2-STAGE, MULTI-CENTRE STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ORAL PTG-100 INDUCTION IN SUBJECTS WITH MODERATE TO SEVERE... 2018-03-26 due-trials
Reported results 2018-001984-21 Phase 2 Study of PTG-300 in Non-Transfusion Dependent (NTD) and Transfusion-Dependent (TD) ß-Thalassemia Subjects with Chronic Anemia Studio di fase 2 di PTG-300 in soggetti affetti da beta-talasse... 2020-03-31 due-trials
Reported results 2018-004423-36 An Open Label Extension Study of PTG-300 in Non-Transfusion Dependent (NTD) and Transfusion-Dependent (TD) ß-thalassemia Subjects Studio di estensione in aperto su PTG-300 in soggetti affetti da be... 2020-04-06 due-trials
Ongoing 2019-004469-41 A Phase 2 Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study to Evaluate the Safety and Efficacy of Oral PN-943 in Subjects with Moderate to Severe Active Ulcerative Coli... not-yet-due
Ongoing 2021-004732-29 A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients with Polycythemia Vera Studio di fase 3 per valutare il mimetico dell’epcidina rusfertide (PTG-300) in pazienti affetti da ... not-yet-due